drugset / Trial / NCT00789971

Triamcinolone Versus Topical Treatment in Post Operative Phacoemulsification

NCT00789971

Completed 150 enrolled Sligo General Hospital
RandomizedSingle-groupSingle-blindTreatment

Summary

Cataract extraction is one of the most common operative procedures performed throughout the world. Conventionally, patients are discharged with postoperative drops of steroids and antibiotics or a combination of both. These drops are to be administered for 2-6 weeks depending on individual eye unit protocol. Many patients find the postoperative drops arduous and non-compliance can cause prolonged inflammation and discomfort. Patients with cognitive, physical and visual impairments require assistance from family or community nurses to administer drops. A single perioperative injection of Triamcinolone has been shown to be an effective replacement for drops postoperatively in two previous studies 1, 2. Aims \& objectives The aim of this study is to see if a single orbital floor injection of Triamcinolone is equivalent to conventional steroid and antibiotic drops used post operatively in uneventful phacoemulsification surgery in treating postoperative inflammation.

Timeline

Start
2007-03
Primary completion
2008-03
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.1 % Topical
Subject Neomycin Unknown Topical
Subject Triamcinolone Acetonide Other / unclassified 40 mg Other

Indications